CSL (CMXHF) Days Sales Outstanding : 57.26 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is CSL Days Sales Outstanding?

CSL's average Accounts Receivable for the six months ended in Dec. 2023 was $2,449 Mil. CSL's Revenue for the six months ended in Dec. 2023 was $7,804 Mil. Hence, CSL's Days Sales Outstanding for the six months ended in Dec. 2023 was 57.26.

The historical rank and industry rank for CSL's Days Sales Outstanding or its related term are showing as below:

CMXHF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.5 Med: 49.81 Max: 68.26
Current: 68.26

During the past 13 years, CSL's highest Days Sales Outstanding was 68.26. The lowest was 32.50. And the median was 49.81.

CMXHF's Days Sales Outstanding is ranked better than
52.47% of 892 companies
in the Biotechnology industry
Industry Median: 72.245 vs CMXHF: 68.26

CSL's Days Sales Outstanding increased from Dec. 2022 (52.08) to Dec. 2023 (57.26).

CSL Days Sales Outstanding Historical Data

The historical data trend for CSL's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Days Sales Outstanding Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

51.24

48.04

37.66

34.14

33.11

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															50.90	62.49	52.08	64.73	57.26

Competitive Comparison of CSL's Days Sales Outstanding

For the Biotechnology subindustry, CSL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSL's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CSL's Days Sales Outstanding falls into.

CSL Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CSL's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (965.8	+	1424)	/	2 )	/	13174	*	365
=	1194.9					/	13174	*	365
=	33.11

CSL's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1424	+	3473)	/	2 )	/	7804	*	365 / 2
=	2448.5					/	7804	*	365 / 2
=	57.26

CSL (OTCPK:CMXHF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

CSL Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CSL's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL (CMXHF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CMXHF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

CSLLY:USA CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.